A Single-Arm, Expanded Access Study of Zanubrutinib (BGB3111) in Patients With B-cell Malignancies

Conditions:   Mantle Cell Lymphoma;   Waldenström Macroglobulinemia Intervention:   Drug: Zanubrutinib Sponsor:   BeiGene Available
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials